


Vésale Bioscience receives €1.8M grant from European Innovation Council for PhageDiag project

EverImmune launches phase I clinical trial for its oncobiotic drug candidate in lung and kidney cancer

Genoscience Pharma announces launch of phase 2b clinical trial of ezurpimtrostat to treat hepatocarcinoma in combination with an immune checkpoint inhibitor and an antiangiogenic agent

Ribonexus appoints Steven Powell as CEO

Quest for health accelerator launches in French Grand Est region with focus on healthcare start-ups

BioWin expands its ‘Growth & Financing’ member service by appointing two industry experts

EverImmune appoints Prof. Laurence Zitvogel as president of scientific advisory board

Enalees opens first subsidiary in the UK
